Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection.

Easterbrook JD, Kash JC, Sheng ZM, Qi L, Gao J, Kilbourne ED, Eichelberger MC, Taubenberger JK.

Influenza Other Respir Viruses. 2011 May;5(3):198-205. doi: 10.1111/j.1750-2659.2010.00191.x. Epub 2011 Jan 25.

2.

Commentary on fatalities in the 1918-1919 influenza pandemic.

Kilbourne ED.

J Infect Dis. 2009 Mar 15;199(6):913; author reply 913-4. doi: 10.1086/597046. No abstract available.

PMID:
19239341
3.

Influenza pandemics of the 20th century.

Kilbourne ED.

Emerg Infect Dis. 2006 Jan;12(1):9-14.

4.

Influenza immunity: new insights from old studies.

Kilbourne ED.

J Infect Dis. 2006 Jan 1;193(1):7-8. Epub 2005 Nov 21. No abstract available.

PMID:
16323125
5.

Intradermal vaccination against influenza.

Kilbourne ED.

N Engl J Med. 2005 Mar 10;352(10):1044-6; author reply 1044-6. No abstract available.

PMID:
15762000
6.

Influenza pandemics: can we prepare for the unpredictable?

Kilbourne ED.

Viral Immunol. 2004;17(3):350-7. Review.

PMID:
15357901
7.

Protection of mice with recombinant influenza virus neuraminidase.

Kilbourne ED, Pokorny BA, Johansson B, Brett I, Milev Y, Matthews JT.

J Infect Dis. 2004 Feb 1;189(3):459-61. Epub 2004 Jan 13.

PMID:
14745703
8.

The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.

Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10748-52. Epub 2002 Jul 22. Erratum in: Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):764..

9.
10.

What are the prospects for a universal influenza vaccine?

Kilbourne ED.

Nat Med. 1999 Oct;5(10):1119-20. No abstract available.

PMID:
10502805
12.
13.

Perspectives on pandemics: a research agenda.

Kilbourne ED.

J Infect Dis. 1997 Aug;176 Suppl 1:S29-31. Review.

PMID:
9240691
14.

In pursuit of influenza: Fort Monmouth to Valhalla (and back).

Kilbourne ED.

Bioessays. 1997 Jul;19(7):641-50.

PMID:
9230697
16.

Humor in science.

Kilbourne ED.

Proc Am Philos Soc. 1996 Sep;140(3):338-49. No abstract available.

PMID:
11613444
17.

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Powers DC, Kilbourne ED, Johansson BE.

Clin Diagn Lab Immunol. 1996 Sep;3(5):511-6.

18.

The emergence of "emerging diseases": a lesson in holistic epidemiology.

Kilbourne ED.

Mt Sinai J Med. 1996 May-Sep;63(3-4):159-66. Review.

PMID:
8692162
19.

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.

Kilbourne ED, Couch RB, Kasel JA, Keitel WA, Cate TR, Quarles JH, Grajower B, Pokorny BA, Johansson BE.

Vaccine. 1995 Dec;13(18):1799-803.

PMID:
8701596
20.

Preparation and characterization of a purified influenza virus neuraminidase vaccine.

Hocart M, Grajower B, Donabedian A, Pokorny B, Whitaker C, Kilbourne ED.

Vaccine. 1995 Dec;13(18):1793-8.

PMID:
8701595
21.

Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants.

Johansson BE, Price PM, Kilbourne ED.

Vaccine. 1995 Jun;13(9):841-5.

PMID:
7483807
22.
23.
25.

Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants.

Kilbourne ED, Johansson BE, Moran T, Wu S, Pokorny BA, Xu X, Cox N.

J Gen Virol. 1993 Jul;74 ( Pt 7):1311-6.

PMID:
8336120
26.

Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice.

Johansson BE, Grajower B, Kilbourne ED.

Vaccine. 1993;11(10):1037-9.

PMID:
8212824
28.
29.
30.

New viruses and new disease: mutation, evolution and ecology.

Kilbourne ED.

Curr Opin Immunol. 1991 Aug;3(4):518-24. Review.

PMID:
1755978
33.

New viral diseases. A real and potential problem without boundaries.

Kilbourne ED.

JAMA. 1990 Jul 4;264(1):68-70.

PMID:
2113105
34.

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.

Kilbourne ED, Johansson BE, Grajower B.

Proc Natl Acad Sci U S A. 1990 Jan;87(2):786-90.

35.

Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies.

Johansson BE, Bucher DJ, Pokorny BA, Mikhail A, Kilbourne ED.

Virology. 1989 Aug;171(2):634-6.

PMID:
2474896
37.
38.
39.

Hemagglutinin polymorphism as the basis for low- and high-yield phenotypes of swine influenza virus.

Kilbourne ED, Taylor AH, Whitaker CW, Sahai R, Caton AJ.

Proc Natl Acad Sci U S A. 1988 Oct;85(20):7782-5.

40.

Presentation of the Academy Medal to Thomas C. Chalmers, M.D.

Kilbourne ED.

Bull N Y Acad Med. 1987 Dec;63(10):912-5. No abstract available.

41.
44.
45.

The emergence of the physician-basic scientist in America.

Kilbourne ED.

Daedalus. 1986 Spring;115(2):43-54. No abstract available.

PMID:
11611952
46.

Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures.

Gallagher M, Bucher DJ, Dourmashkin R, Davis JF, Rosenn G, Kilbourne ED.

J Clin Microbiol. 1984 Jul;20(1):89-93.

47.

The genetic dissection of viral virulence.

Kilbourne ED.

Ann N Y Acad Sci. 1984;435:32-8. No abstract available.

PMID:
6598006
48.
49.
50.

Detection of antibodies to influenza virus M protein by an enzyme-linked immunosorbent assay.

Khan MW, Bucher DJ, Koul AK, Kalish G, Smith H, Kilbourne ED.

J Clin Microbiol. 1982 Nov;16(5):813-20.

Supplemental Content

Loading ...
Support Center